May 12, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
Focus Conference in Glasgow puts spotlight on how medical laboratories must deliver more testing with less reimbursement
Clinical pathology laboratory services might be considered “under siege” in the United Kingdom. That’s because clinical laboratories are facing significant reductions to their annual budgets, even as health trusts throughout the country push for regional integration and further consolidation of laboratory testing services.
This week in Glasgow, Scotland, the Association for Clinical Biochemistry is conducting Focus, its annual meeting. This large gathering for the laboratory medicine profession in the United Kingdom offers attendees a wide spectrum of topics and speakers relating to laboratory testing. Your Dark Daily Editor is here to chair a session, learn from the many interesting presentations, and visit some hospital laboratories in Glasgow.
(more…)
Apr 16, 2010 | Laboratory News, Laboratory Pathology, News From Dark Daily
Third-generation total laboratory automation (TLA) solutions now used by Japanese clinical labs
Your Dark Daily editor is writing this e-briefing from the 7th Cherry Blossom Symposium in Japan, where it is already Saturday—one day ahead of you readers in North America! The second day of this International Conference of Clinical Laboratory Automation and Robotics is now unfolding.
Yesterday’s opening sessions were chock-full of innovation, insights, and new developments in clinical laboratory automation and robotics. Representing 12 nations, a sizeable crowd of 260 pathologists, clinical biochemists, laboratory scientists, and in vitro diagnostics (IVD) vendors is in attendance.
(more…)
Apr 6, 2010 | Instruments & Equipment, Laboratory News, Laboratory Pathology
Cherry Blossom Symposium attracts pathologists from across the globe
Many of the world’s most innovative pathologists and experts in clinical laboratory automation are about to gather in Yokohama, Japan, for the 7th International of Conference of Clinical Laboratory Automation and Robotics —also known as the Cherry Blossom Symposium. The conference will take place on April 16-17, 2010.
In the United States, few clinical laboratory professionals and pathologists are aware that the Cherry Blossom Symposium takes place every other year in Japan. Yet, since its inception in 1998, it has been a “must-attend” event for North American laboratory automation innovators. Such well-known clinical laboratory automation experts as Charles Hawker, Ph.D., of ARUP Laboratories; Rodney Markin, M.D., Ph.D., of University of Nebraska Medical Center; and Robin Felder, Ph.D., of University of Virginia, make a point to participate at every Cherry Blossom Symposium.
(more…)
Apr 2, 2010 | Laboratory News, Laboratory Pathology
Latest example of a larger company spinning off its laboratory consulting businesses
For the second time in recent years, a large organization has spun off its clinical laboratory consulting business. As of April 1, 2010, Chi Solutions, Inc., of Ann Arbor, Michigan, once again became an independent company.
Carilion Clinic of Roanoke, Virginia, sold Chi Solutions to Kathleen Murphy, Ph.D., and Earl Buck. It was April, 2005 when Carilion Clinic originally acquired the Laboratory Solutions Group of Park City Solutions and named it Chi Solutions. Murphy and Buck have been the principal consultants at Chi Solutions.
(more…)
Feb 25, 2010 | Laboratory News, Laboratory Pathology
Both companies are important suppliers to clinical laboratories and research labs
In recent days, news surfaced that Thermo Fisher Scientific Inc. (NYSE: TMO) was offering $6 billion to acquire Millipore Corporation (NYSE:MIL). Neither company has confirmed the offer, but yesterday Millipore issued a statement that its Directors were “evaluating strategic options.”
Should Thermo Fisher acquire Millipore, or should Millipore find another buyer, it will mean the same thing: more consolidation among vendors who are major suppliers for clinical pathology laboratories. This would continue a global consolidation trend among clinical laboratory suppliers and in vitro diagnostics (IVD) manufacturers that reaches back more than a decade and a half.
(more…)
